Rabies Exposure Implications for Wilderness Travelers

Size: px
Start display at page:

Download "Rabies Exposure Implications for Wilderness Travelers"

Transcription

1 Wilderness and Environmental Medicine, 20, (2009) CASE REPORT Rabies Exposure Implications for Wilderness Travelers Evan T. Miller, MD; Regan H. Marsh, MD; N. Stuart Harris, MD, MFA, FACEP From the Indiana University School of Medicine, Indianapolis, IN (Dr Miller); the Harvard Affiliated Emergency Medicine Residency, Brigham and Woman s and Massachusetts General Hospital, Boston, MA (Dr Marsh); and the Department of Emergency Medicine, Massachusetts General Hospital and Harvard School of Medicine, Boston, MA (Dr Harris). Rabies is a preventable, fatal infectious disease. Successful vaccination programs for domestic animals in developed countries have drastically decreased the risk of exposure to rabies. Yet awareness of rabies needs to remain high as important reservoirs still exist in our backyards, the wilderness, and abroad. Recognizing the risk before and after a potential exposure, so that appropriate medical care can be sought, is critical to preventing a fatal complication. This case report involves an exposure of a medical student to an ill-appearing and likely rabid gray fox in the Gila Wilderness Area of New Mexico. The student was a member of a 28-day wilderness medicine course taught by the National Outdoor Leadership School/Wilderness Medicine Institute in collaboration with the Harvard Affiliated Emergency Medicine Residency. On the first night in the field, the student awoke to a gray fox biting his foot through his sleeping bag in the early morning hours. Subsequently the student was evacuated for medical evaluation. Further care consisted of rabies postexposure prophylaxis, including thorough wound cleansing, injection of human rabies immunoglobulin, and initiation of a rabies vaccination schedule. Immediate wound care with soap and water and a viricidal agent is of utmost importance for any animal bite, but especially so in the prevention of rabies. Indications for rabies prophylaxis are complex and require prompt evaluation by a medical professional and consultation with local epidemiology to guide treatment. Key words: rabies, Gray fox, wild animals, animal bite, wilderness medicine Introduction Rabies presents as an acute progressive encephalitis that is fatal. Whereas clinical rabies is an infrequently encountered disease in the developed world, substantial reservoirs of the disease are present in the United States. Although rabies in domestic animals has been drastically decreased, numerous wild animal vectors exist and present an exposure risk in the wilderness setting. Case report Corresponding author: Evan T. Miller, MD, Indiana University School of Medicine, Indianapolis, IN ( evtmille@gmail. com). The Wilderness Medicine Institute of National Outdoor Leadership School (NOLS) in partnership with the Harvard Affiliated Emergency Medicine Residency and the Massachusetts General Hospital Director of Wilderness Medicine leads a 28-day course, Medicine in the Wild, for third- and fourth-year medical students. Medicine in the Wild consists of a 48-hour, classroom-based clinical section (Wilderness Upgrade for Medical Professionals), followed by a 20-day field portion in the Gila Wilderness Area, New Mexico. On the first night of the field section, a healthy 25- year-old student sleeping outside of a kiva shelter was awakened at 0430 hours by foot pain to find a fox biting through his sleeping bag. Despite immediate yelling and movement, the fox only released its bite and ran off after the student was able to slide an arm out of his mummy bag, strike the fox with a trekking pole twice, and then stand up still in his sleeping bag. After waking other students and instructors, it was discovered that earlier in the evening students in another tent group (located approximately 500 m away) had been awakened by a fox walking on their sleeping bags inside their kiva shelter. In addition, the fox had dragged away

2 Rabies for Wilderness Travelers 291 boots and other items before it was scared away. No bites or direct contact with the fox were noted to have occurred at this time. On examination of the bitten student, a 1 cm superficial transdermal skin avulsion located on the medial aspect of the fourth digit of the right foot was documented. In addition, an obvious tear and puncture holes were present at the foot of the sleeping bag. No other bites were apparent. The wound was immediately irrigated with 2 L of water previously treated with chlorine dioxide, and the wound was disinfected with direct application of 2% aqueous chlorine dioxide by an additional course participant, a Harvard Affiliated Emergency Medicine Residency senior resident physician. After the attack, the fox was intermittently spotted lurking in the dark outside of camp. The course instructors brought all the students to a central area, and a fire was started. The fox repeatedly tried to re-enter the camp area. In an attempt to drive off the oddlybehaving fox on one incursion, an instructor was successful in striking it with 2 stones. Subsequent attempts to locate the fox were unsuccessful. Once daylight arrived, NOLS s Southwest Branch emergency coordinator was contacted via satellite phone to discuss the incident. An evacuation and transportation plan was devised, and oral cephalexin was initiated. An evacuation team consisting of the (fully ambulatory) bitten student, an instructor, a resident physician, and an additional student departed at 0900 hours on a 3-mile evacuation hike to the trailhead. From the trailhead the patient was transported by a previously positioned NOLS vehicle and arrived at a regional medical center at approximately 1300 hours that same day. At the medical facility, additional wound cleansing was done with povidone-iodine solution while the local treating emergency physician sought consultation with the New Mexico State Department of Health epidemiologist. After consultation, the emergency physician initiated rabies postexposure prophylaxis (PEP). The bite site was infiltrated with 2 ml of human rabies immunoglobulin (HRIG), and an additional 10 ml of HRIG was injected intramuscularly into bilateral gluteal muscles. Rabies vaccination was initiated in New Mexico and completed in the student s home state using 1.0 ml human diploid cell-purified vaccine (HDCV) administered intramuscularly in the deltoid region using the Essen Protocol of vaccine on days 0, 3, 7, 14, and 28. A tetanus booster was given at the initial emergency room visit, and cephalexin was discontinued. Early investigations were made by the evacuation team as to the feasibility of acquiring necessary doses of rabies vaccine (to be released to the accompanying licensed physician), which might enable the student to complete his vaccination schedule in the field. Although potentially technically feasible, given the potentially fatal downside of inadequate PEP, the decision was made by NOLS that the student should not return to the field. The remainder of the evacuation team then returned to the field and completed the full 20-day field section without incident. The student returned home and completed the PEP for rabies following the recommended schedule by the Advisory Committee on Immunization Practices (ACIP). 1 Discussion Awareness of rabies needs to remain high as important reservoirs still exist in populated domestic regions, the wilderness, and abroad. After an exposure, if PEP is not initiated empirically and effectively and clinical rabies develops, it is fatal. Although rare cases of survival of clinical rabies have been reported using various treatment protocols, none has proven effective. 2 Only 2 cases with mild to no neurologic sequelae have been documented, most notability a case involving the Milwaukee Protocol; however it has been unsuccessful in subsequent cases. 3 7 Prevention remains the only reasonable option. Worldwide, exposure to rabies from wild and domestic animals results in an estimated deaths per year, which occur almost entirely in the developing world. 8 In the United States and most developed countries, implementation of rabies control programs (most notably extensive vaccination programs of domestic animals in the 1940s) dramatically decreased the incidence of rabies in domestic animals by the 1960s. 9 Since that time the prevalence of rabies in wild animal reservoirs has become more apparent and now represents the dominant exposure risk in the developed world. Wild animals accounted for 93% of rabid animals in the United States during 2007 based on Center for Disease Control and Prevention (CDC) surveillance. 10 Despite advances in the eradication of domestic reservoirs, 1 to 2 deaths per year from rabies occur and an average of to people undergo PEP annually in the United States. 11 Rabies prophylaxis is very effective, with no failures documented for correctly completed vaccination series in the United States since cell-purified vaccines have been utilized. 12 Proper recognition of exposure risk is pivotal in the prevention of rabies in humans, so that preexposure prophylaxis and PEP can be instituted. Of note, in one study in the United States it has been reported that in as many as 40% of cases in which PEP was given, it was not necessary. Perhaps of more concern, this study reported that an even higher rate existed where PEP was indicated and was not given. 13 Physician education of the

3 292 Miller, Marsh, and Harris guidelines for rabies prophylaxis and the low threshold for utilization of local public health agencies in questionable cases has been suggested and shown to improve PEP utilization. In New Mexico, where the exposure occurred, such a system has been in place since the 1980s and has improved utilization of rabies PEP. 14 The correct utilization of vaccine is of increased importance because a limited supply of vaccine is currently available, only for use in PEP, from both major suppliers of vaccine (Sanofi Pasteur and Novartis). Because of this limited supply, vaccine for pre-exposure prophylaxis is temporarily unavailable to ensure availability for PEP. Supply limitations have resulted from regulatory issues, increased demand, and limited production (Sanofi Pasteur s facility is nonoperational until mid- to late-2009 because of renovations). Currently, RabAvert (Novartis) is available for PEP without restrictions, whereas the availability of Imovax (Sanofi Pasteur) first requires consultation with a rabies state health official for risk assessment. 15 It should be anticipated that the vaccine supply will remain limited for the foreseeable future. Expert consultation with public health can improve utilization. Rabies is caused by an RNA virus from the lyssavirus genus, of the Rhabdoviridae family. The virus is bulletshaped and adapted to replicate in the mammalian central nervous system. 16 The importance of each terrestrial endemic rabies reservoir varies with geographic area. In the United States, terrestrial rabies reservoir species include raccoons (Procyon lotor); striped and spotted skunks (Mephitis mephitis, Spilogale putorius and S gracilis); red (Vulpes vulpes), gray (Urocyon cinereoargenteus), and arctic foxes (Alopex lagopus); coyotes (Canis latrans); and mongooses (Herpestes javanicus) in Puerto Rico. 9,16 Any bat represents an exposure risk to rabies; however, species of specific note are the silverhaired bat (Lasionycteris noctivagans) and the eastern pipistrelle (Pipistrellus subflavus). 17 The incidence of rabies and defined geographic areas in enzootic reservoirs varies with time. Rodents and lagomorphs are not true reservoirs of rabies. Intermittent transmission of rabies from enzootics species to other mammals results in cases of spillover, with these atypical mammals then testing positive. 10 Exposure to rabies virus from animals can be broken into categories of bite and nonbite exposures. 1 Transmission of rabies to humans typically occurs when virus, excreted in the saliva of the animal, is introduced by the bite of an overtly infected animal. Nonbite exposures can occur from a scratch by a paw contaminated with the saliva of a rabid animal, contact of infected saliva or neural material with mucosal surfaces, or inhalation of large amounts of aerosolized rabies virus. 1 Rabies cannot be transmitted through intact skin. 16,18 While the presence of the virus in the saliva of infected animals typically occurs concomitantly with clinical signs, the presence of rabies in the saliva of a rabid animal can occur several days before the development of signs. Based on the pathogenesis of rabies, virus must be present in the central nervous system for there to be excretion into saliva; although the animal may appear healthy, testing of the animal s central nervous system will be positive. 12,19 Wild mammals can be divided into 3 important categories in terms of exposure to rabies and need for PEP: terrestrial mammalian carnivores, bats, and other wild mammals (Table). Exposure to terrestrial mammalian carnivores tends to be obvious and memorable, in the form of an attack, resulting in noticeable bite and scratch injuries. 1 Terrestrial mammalian carnivores are regarded as rabid unless proven negative for rabies by diagnostic testing. Immediate initiation of PEP is recommended. 1 The extent of contact with a bat may be difficult to determine, and bite or scratch injuries can be difficult to detect. 12 The ACIP guidelines for initiation of PEP for bat exposures reflect this difficulty. To emphasize this point, the majority of cases of clinical human rabies acquired in the United States in recent years are found to be caused by bat variants and often without patient recall of exposure. 20 Therefore, a simplified recommendation is that any direct contact with a bat should be considered an exposure risk and evaluated for initiation of PEP. Postexposure prophylaxis is likely indicated unless the bat is available and tests negative for rabies. 1 A Department of Health consultation is strongly advised. A third wild animal category includes other mammals. Small rodents and lagomorphs are almost never found to be rabid and not known to transmit rabies to humans. Incidents of rabid large rodents including woodchucks and beavers (Marmota monax and Castor canadensis) in the Mid-Atlantic States occur in areas where rabies is enzootic in raccoons. 9 Many other mammals not typically associated with rabies have sporadically tested positive for rabies. 10 We would again stress the recommendation by the ACIP that any patient who is bitten by a wild animal should seek medical care and guidance from local and state health agencies. 1,21 The gray fox reservoir of rabies has been endemic to areas of Texas and Arizona for decades. 10 During 2007, 8 cases of rabid gray foxes were newly reported in southwestern New Mexico in Catron County, an area not previously noted to harbor this rabies potential. By October 2008, an additional 16 infected gray foxes were documented in an increasingly broad geographic area. In New Mexico, the gray fox now represents the majority of

4 Rabies for Wilderness Travelers 293 Table. Indications for rabies postexposure prophylaxis from wild animal exposures based on Advisory Committee on Immunization Practices recommendations 1 Wild mammal* Likelihood of rabies Terrestrial carnivore (skunks, raccoons, foxes, etc) Regard as rabid unless proven otherwise by Bats Regard as rabid unless proven otherwise by laboratory Large rodents/lagomorphs (woodchucks, beavers, rabbits and hares){ Consider individually guided by local laboratory epidemiology Bite Immediate PEP Immediate PEP ; frequently requires PEP NonbiteI Bat (contact type unknown)" Other mammals (small rodents, deer, etc){ Unlikely, consider individually guided by local epidemiology ; almost never requires PEP ; almost never requires PEP *Recommendations for wild animals only, for domestic animal bites/contacts, observation of animal for signs of rabies is reliable. In any wild animal attack/bite expert medical guidance should be sought. {Woodchucks and beavers have an increased frequency of being rabid in areas were rabies is enzootic in raccoons, but are not natural reservoirs of rabies. {Not known to transmit rabies to humans but prophylaxis may be indicated. Signs of rabies in wild animals not reliably interpreted. If animal is available, prompt euthanasia and expedited testing for rabies can be initiated. IIncludes scratches, contact of saliva/neural material with open wounds (cuts, abrasions, scratches), or contact with mucosal surfaces. "Bat exposures should be taken seriously. If a bite/scratch potentially occurred, it should be considered to have occurred, because bat bites may be difficult to see, but are still capable of transmitting rabies. PEP 5 Postexposure prophylaxis. 25 animals that have tested positive for rabies during ,23 Previously cases of rabid wild animals in New Mexico were predominantly recorded in skunks and bats; however, neighboring states Arizona and Texas reported 22 and 31 cases, respectively, in gray foxes during 2007, both increases from previous years. 10 The additional extension of gray fox variant rabies has been observed along the Pecos River in Texas, suggested to have been driven by recent years of drought in the region. 10 Specifically in the area of the Gila Wilderness Area where the attack reported here occurred (the Catwalk), 3 attacks by gray foxes on hikers have been reported: 1 in 2007 resulting in trail closure and an additional attack occurring earlier in the same month as this report. 22 Gradual expansion of endemic rabies in a species geographical area is common and sometimes occurs precipitously and in this case is likely spillover from Arizona into a susceptible animal population. 10 Although the signs of rabid wild animals cannot be reliably interpreted, the fox in this case was very suspicious for being rabid (an unprovoked attack of a sleeping victim by an oddly-behaving animal that had lost fear of humans). Regardless, any bite by the gray fox, a terrestrial carnivore known to be a reservoir of rabies, is independently at high risk of exposure to rabies. 1,18 Exposure in this case occurred via a transdermal bite, for which the ACIP recommends immediate PEP. 1 Whether in an urban or wilderness setting, prophylaxis of a suspected rabies exposure should begin with good wound management, focusing on immediate cleansing of the wound with soap and water as thoroughly as possible and with application of a virucial antiseptic such as povidone iodine or alcohol. Thorough wound care has been shown to drastically decrease rabies infection rates. 18 In this case, neither iodine nor alcohol was immediately available (searching through first aid kits in the dark), however, aqueous chlorine dioxide used by the course participants for disinfecting drinking water was substituted. Although not preferred because of its caustic nature, chlorine dioxide is known to be virucial and was readily available. 24 Wound care is likely the extent of care advisable in the wilderness setting. Additional wound treatment, including antibiotics and tetanus vaccination, should be guided as clinically indicated by conventional wound care of an animal bite. Primary closure with suture should be avoided. 1 In this case the wound was very superficial and not a true puncture wound, therefore antibiotics were discontinued. Suspected rabies exposure in general is a medical urgency, but not emergency, and requires definitive medical care (the initiation of PEP) preferably within 24

5 294 Miller, Marsh, and Harris to 48 hours. Although early initiation is prudent, PEP should certainly be pursued even if lengthy delay has occurred. 1 Any significant delay in PEP would place the patient at unnecessary risk, as cases of reported failures of PEP have been attributed to a delay in initiation. 25 In this case, evacuation was atypically brisk, a short evacuation hike of 3 miles to reach a course van. Waiting until morning light to assess options and coordinate an orderly evacuation, so as not to pose additional risk to the team, was prudent. An evacuation team of 4 was organized using NOLS protocol for an ambulatory evacuee. The goal with an evacuation group size of 4 is redundancy. A team of 4 has enough resources to be self-contained, to split up if another injury/illness occurs, to have good decision-making processes, and to maintain optimal safety. Although not always possible, NOLS policy is to send an evacuation group of 4 as often as can be managed. In addition to appropriate wound care, PEP involves both passive and active immunization of the patient to the rabies virus. Rabies immunoglobulin (RIG) is administered to provide immediately-effective, virusneutralizing antibodies. Administration of a course of approved rabies vaccine provides a lasting immune response. In the United States, only RIG of human origin (HRIG) is used in PEP, whereas outside of the United States other biologics (equine origin) are available. 1 Internationally, the World Health Organization recommendations prefer the use of HRIG over the other passive biologics available but use is constrained by limited availability. 18 Human rabies immunoglobulin is given at a dose of 20 IU/kg, with as much of the dose administered at the exposure site as anatomically possible, taking care to thoroughly infiltrate all wounds. Any remaining HRIG is administered distant to the vaccination site intramuscularly. 1,21 In this case, given the distal digital nature of the wound, the volume of HRIG locally administered at the exposure site was limited to 2 ml of the total 12 ml dose. The remainder of the HRIG dose was administered intramuscularly to bilateral gluteal muscles. Concern of causing compartment syndrome from injection of HRIG into a digit has been raised, as a large number of bites occur on digits; however, no evidence of circulation compromise has been noted when injection is carried out by experienced providers. 26 In the United States, 2 purified cell vaccines are available for rabies vaccination: HDCV (Imovax) and purified chick embryo cell vaccine (RabAvert). In this case, vaccination was carried out in accordance with ACIP guidelines with HDCV: 1.0 ml administered IM in the deltoid region following the Essen Protocol of vaccination on days 0, 3, 7, 14, and 28. In patients that have received pre-exposure rabies prophylaxis, HRIG is not necessary as the patient already has developed antibodies to bind rabies virus. In these previously vaccinated patients, a shortened immunization schedule with 1.0 ml of vaccine administered on days 0 and 3 is used. 1 All vaccinations should be given intramuscularly to the deltoid in adults and may be given in the anterolateral thigh in children. In contrast to HRIG, rabies vaccines should never be administered in the gluteal area as it has been associated with decreased efficacy and PEP failure. 21,25 Rabies vaccine should never be administered at the same site as HRIG or using the same needle/syringe. 21 Reported cases of modern PEP failure, although exceedingly rare, are thought to have resulted from deviation from strict adherence to PEP guidelines. 25 Identified errors in prophylaxis include: no injection, insufficient injection, or failure to locally inject RIG at the wound site; insufficient wound care; additional small unidentified and untreated wounds; delay in seeking PEP; and injection of vaccine into gluteal muscles, which is associated with poor vaccine response. 21,25,27 Yet there are cases documented where modern PEP appears to have been administered appropriately but failed. Potential risk factors for failure of PEP include virus inoculation into highly innervated areas of the body, including the hands and face; direct inoculation into peripheral nerves, thereby by-passing protection from RIG; large viral inoculum or severe wounds; dog bites; and an unidentified immunocomprised state. 25,27 Small unknown or unreported deviations from PEP treatment protocol cannot be excluded. This stresses that PEP be guided by Department of Health consultation in the hands of an experience clinician. Of note, no PEP failures have occurred in the United States since cell culture vaccines have become standard. 21 The risk of exposure to rabies from bats is underappreciated by many including those at particular risk cavers and spelunkers. Rabies is present in bats throughout the United States, excluding Hawaii. 10 The majority of human rabies cases acquired in the United States in recent decades have been bat variants. 20 Since the 1960s, it has been advised that cavers receive preexposure prophylaxis to rabies. However, a study conducted at the National Speleological Society Convention in 2000 found that 15% of respondents thought that a bite from a bat was not a risk for acquiring rabies and only 20% had received rabies prophylaxis. 28 Cavers risk exposure to rabies from bats through direct contact resulting in a bite or potentially by scratch or mucous membrane exposure. Aerosol transmission of rabies has been proposed as the cause of a few human cases, but

6 Rabies for Wilderness Travelers 295 data remain limited. The 2 cases of human rabies attributed to aerosol transmission in caves are based on weak historical evidence and are more likely to have occurred from bites or direct exposure. 29 At the backcountry wilderness medical course for senior medical students, a licensed physician was part of the field and evacuation team a resource not often available. With this physician s input, a plan to return to the field with the necessary supplies to continue the vaccination series in the backcountry was considered. A primary concern included an assessment of the logistics of safely storing the vaccine. Systems to assure temperature-controlled storage of the vaccine were investigated in collaboration with the medical director of the vaccine manufacturer. An additional assurance of vaccine stability was provided by a stability indicator included in standard vaccine preparations. In addition, HDCV has been shown to be stable and effective at the temperatures likely to be encountered at the course for greater than the duration of the vaccination schedule; however, such storage is not recommended by the manufacturer. 30 These reassuring factors notwithstanding, numerous obvious reasons remained to not pursue this course. Transporting a system of PEP known to be very effective and safe in a traditional clinical setting into the backcountry, where uncertainty is commonplace and limited resources are the rule, places the patient at an unnecessary risk of potential failure of PEP with a consequence of certain death. A bite from any animal in the wilderness setting warrants evacuation for further assessment and management. In this case, the risk of rabies exposure is obvious, with an aggressive, small, mammalian carnivore without fear of humans acting almost cartoonishly out of the ordinary. In different cases, the exposure risk may not be as readily apparent, such as after inadvertent contact with bats or a bite from an animal not typically associated with rabies transmission. Ultimately the exposure should be evaluated by a medical provider in consultation with public health authorities outside the backcountry setting. This case illustrates that even when there is an abundance of sophisticated medical professional care in the field, requirements for prophylaxis make any suspected rabies exposure an indication for immediate evacuation. Also of note from this case is the critical need for up-to-date surveillance by public health. This case also highlights the importance of newly expanding territories and potential changes in wild animal vectors. As local and global environmental changes occur, it should be expected that the potential for new patterns of rabies endemic ranges and species will demand continued study and careful public health surveillance. Acknowledgments The authors would like to thank the National Outdoor Leadership School and Wilderness Medicine Institute community including Gates Richards, Dave Weber, John Hovey, Julia Fairbank, and Tod Schimelpfenig for their help, professional abilities, and passion for outdoor education. Note: The US Center for Disease Control maintains an expert consultation hotline available 24 hours/7 days a week at (877) References 1. Centers for Disease Control and Prevention. Human rabies prevention United States Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep Early Release. 2008;57:1 26, Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis. 2003;36: Hattwick MA, Weis TT, Stechschulte CJ, Baer GM, Gregg MB. Recovery from rabies: a case report. Ann of Intern Med. 1972;76: Willoughby RE, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352: Hu WT, Willoughby RE, Dhonau H, Mack KJ. Long-term follow-up after treatment of rabies by induction of coma. N Engl J Med. 2007;357: Centers for Disease Control and Prevention. Human rabies Alberta, Canada, MMWR Mnb Mortal Wkly Report. 2008;57: US Centers for Disease Control and Prevention. Human rabies Indiana and California, MMWR Morb Mortal Wkly Rep. 2007;56: Knobel DL, Cleaveland S, Coleman PG, et al. Reevaluating the burden of rabies in Africa and Asia. Bulletin of the World Health Organization. 2005;83: Krebs JW, Mandel EJ, Swerdlow DL, Rupprecht CE. Rabies surveillance in the United States during JAm Vet Med Assoc. 2005;227: Blanton JD, Palmer D, Christian KA, Rupprecht CE. Rabies surveillance in the United States during JAm Vet Med Assoc. 2008;233: Krebs JW, Long-Marin SC, Childs JE. Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States. J Public Health Manag Pract. 1998;4: Rupprecht CE, Gibbons RV. Prophylaxis against rabies. N Engl J Med. 2004;351: Moran GJ, Talan DA, Mower W, et al. Appropriateness of rabies postexposure prophylaxis treatment for animal exposures. JAMA. 2000;284: Mann JM, Burkhart MJ, Rollang OJ. Anti-rabies treatments in New Mexico: impact of a comprehensive consultationbiologics system. Am J Public Health. 1980;70: CDC News Release. Rabies vaccine supply situation vaccination 10/08/08. Available at:

7 296 Miller, Marsh, and Harris RABIES/news/RabVaxupdate.html. Accessed December 6, Nel LH, Markotter W. Lyssaviruses. Crit Rev Microbiol. 2007;33: Messenger SL, Smith JS, Rupprecht CE. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin Infect Dis. 2002;35: WHO Expert Consultation on Rabies First Report. Technical Report Series 931. Geneva, Switzerland: World Health Organization; Smith, JS. New aspects of rabies with emphasis on epidemiology, diagnosis, and prevention of the disease in the United States. Clin Microbiol Rev. 1996;9: CDC. Rabies, Epidemiology United States Rabies Surveillance Data Available at: rabies/epidemiology.html. Accessed December 6, Centers for Disease Control and Prevention. Human rabies prevention United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48(RR-1): New Mexico Department of Health. Second fox from Silver City tests positive for rabies; hiker bitten by fox (3/ 20/08). Available at: rabies.html. Accessed December 6, New Mexico Department of Health. Animal rabies by county, New Mexico, 10/30/2008. Available at: html. Accessed December 6, Taylor GR, Butler M. A comparison of the virucidal properties of chlorine, chlorine dioxide, bromine chloride and iodine. J Hyg. 1982;89: Wilde H. Failures of post-exposure rabies prophylaxis. Vaccine. 2007;25: Suwansrinon K, Aijaroensup W, Wilde H, Sitprija V. Short report: is injecting a finger with rabies immunoglobulin dangerous? Am J Trop Med Hyg. 2006;75: Haupt, W. Rabies risk of exposure and current trends in prevention of human cases. Vaccine. 1999;17: Gibbons RV, Holman RC, Mosberg SR, Rupprecht CE. Knowledge of bat rabies and human exposure among United States cavers. Emerg Infec Dis. 2002;8: Gibbons RV. Cryptogenic rabies, bats, and the question of aerosol transmission. Ann Emerg Med. 2002;39: Nicholson K, Burney M, Ali S, Perkins F. Stability of human diploid-cell-strain rabies vaccine at high ambient temperatures. Lancet. 1983;1:

Rabies Epidemiology K require rabies post-exposure prophylaxis annually. Medical urgency, not medical emergency $300 million annually

Rabies Epidemiology K require rabies post-exposure prophylaxis annually. Medical urgency, not medical emergency $300 million annually Rabies Rabies Epidemiology 16-39K require rabies post-exposure prophylaxis annually Medical urgency, not medical emergency $300 million annually About 1 or 2 cases of rabies annually in US Sources of Exposure

More information

Protocol for Rabies Post-exposure Prophylaxis (RPEP) After Exposure to a Rabies Susceptible Animal 1,2

Protocol for Rabies Post-exposure Prophylaxis (RPEP) After Exposure to a Rabies Susceptible Animal 1,2 Protocol for Rabies Post-exposure Prophylaxis (RPEP) After Exposure to a Rabies Susceptible Animal 1,2 Post-exposure Rabies Vaccine Schedule Update The March 19, 2010 issue of the Centers for Disease Control

More information

Rabies Prevention and Post- Deployment Assessments: Information for Providersand Public Health Personnel

Rabies Prevention and Post- Deployment Assessments: Information for Providersand Public Health Personnel U.S. Army Public Health Command Public Health Notice Rabies Prevention and Post- Deployment Assessments: Information for Providersand Public Health Personnel December 2012 U.S. Army Public Health Command

More information

Policy Statement Rabies-Prevention Policy Update: New Reduced-Dose Schedule

Policy Statement Rabies-Prevention Policy Update: New Reduced-Dose Schedule FROM THE AMERICAN ACADEMY OF PEDIATRICS Organizational Principles to Guide and Define the Child Health Care System and/or Improve the Health of all Children Policy Statement Rabies-Prevention Policy Update:

More information

GUIDELINES FOR MANAGEMENT OF SUSPECTED RABIES EXPOSURES January, 2010

GUIDELINES FOR MANAGEMENT OF SUSPECTED RABIES EXPOSURES January, 2010 Ministry of Health and Long-Term Care Ministère de la Santé et des Soins de longue durée GUIDELINES FOR MANAGEMENT OF SUSPECTED RABIES EXPOSURES January, 2010 All suspected incidents must be reported to

More information

Considerations for Tetanus While Treating an Exposure to Rabies

Considerations for Tetanus While Treating an Exposure to Rabies Considerations for Tetanus While Treating an Exposure to Rabies Since rabies and tetanus are not as common in the United States (US) as they used to be, 1,2 people may not be fully aware of these diseases

More information

RABIES. Zeliha Koçak Tufan, MD, Assoc. Prof. Yildirim Beyazit University Infectious Diseases & Clinical Microbiology Department

RABIES. Zeliha Koçak Tufan, MD, Assoc. Prof. Yildirim Beyazit University Infectious Diseases & Clinical Microbiology Department RABIES Zeliha Koçak Tufan, MD, Assoc. Prof. Yildirim Beyazit University Infectious Diseases & Clinical Microbiology Department Please focus on the pathogenesis and prophylaxis plus wound care!! What is

More information

NEW JERSEY DEPARTMENT OF HEALTH & SENIOR SERVICES

NEW JERSEY DEPARTMENT OF HEALTH & SENIOR SERVICES NEW JERSEY DEPARTMENT OF HEALTH & SENIOR SERVICES NEW JERSEY GUIDE TO POST-EXPOSURE RABIES PROPHYLAXIS FOR THE HEALTH CARE PROFESSIONAL July 2011 BACKGROUND Raccoon rabies entered New Jersey in the fall

More information

RABIES PROTECTION PROGRAM

RABIES PROTECTION PROGRAM Page 1 of 5 STANDARD OPERATING PROCEDURES (SOP) SCOPE Rabies is a virus causing an acute central nervous system infection, which is typically transmitted by introducing the rabies virus into open cuts

More information

NEW YORK STATE DEPARTMENT OF HEALTH Updated February 1, 1999 Rabies Policies and Procedures (518) (518) (after hours)

NEW YORK STATE DEPARTMENT OF HEALTH Updated February 1, 1999 Rabies Policies and Procedures (518) (518) (after hours) NEW YORK STATE DEPARTMENT OF HEALTH Updated February 1, 1999 Rabies Policies and Procedures (518) 474-3186 (518) 465-9720 (after hours) SUBJECT: Guidance Regarding Human Rabies Exposure and Treatment Decisions

More information

This is risky. Rabies. Are you at risk?

This is risky. Rabies. Are you at risk? This is risky. Rabies Are you at risk? Are you at risk of rabies? You are at risk if you are in contact with potentially rabid animals: t Laboratory workers, veterinarians t Animal control workers, animal

More information

Canadian Immunization Guide

Canadian Immunization Guide Home > Immunization & Vaccines > Canadian Immunization Guide > Rabies Vaccine Canadian Immunization Guide T [Previous page] [Table of Contents] [Next page] Part 4 Active Vaccines Rabies Vaccine Epidemiology

More information

Twelve Common Questions About Human Rabies and Its Prevention

Twelve Common Questions About Human Rabies and Its Prevention Published in Infectious Diseases in Clinical Practice (2000) 9:202-207 Twelve Common Questions About Human Rabies and Its Prevention Robert V. Gibbons, MD, MPH Charles Rupprecht, DVM Viral and Rickettsial

More information

Guidance Document for the Management of Suspected Rabies Exposures

Guidance Document for the Management of Suspected Rabies Exposures Guidance Document for the Management of Suspected Rabies Exposures This document is in support of the Rabies Prevention and Control Protocol, 2008 (or as current) under the Ontario Public Health Standards.

More information

OREGON PUBLIC HEALTH DIVISION IMMUNIZATION PROTOCOL FOR PHARMACISTS RABIES INACTIVATED VIRUS VACCINE FOR PRE-EXPOSURE PROPHYLAXIS ONLY

OREGON PUBLIC HEALTH DIVISION IMMUNIZATION PROTOCOL FOR PHARMACISTS RABIES INACTIVATED VIRUS VACCINE FOR PRE-EXPOSURE PROPHYLAXIS ONLY OREGON PUBLIC HEALTH DIVISION IMMUNIZATION PROTOCOL FOR PHARMACISTS RABIES INACTIVATED VIRUS VACCINE FOR PRE-EXPOSURE PROPHYLAXIS ONLY Review 06-2010 No changes to the PRE-EXPOSURE protocol of 2008. See

More information

Mammalian Reservoirs and Epidemiology of Rabies Diagnosed in Human Beings in the United States,

Mammalian Reservoirs and Epidemiology of Rabies Diagnosed in Human Beings in the United States, Mammalian Reservoirs and Epidemiology of Rabies Diagnosed in Human Beings in the United States, 1981 1998 JOHN W. KREBS, a JEAN S. SMITH, CHARLES E. RUPPRECHT, AND JAMES E. CHILDS Viral and Rickettsial

More information

Epidemiology of Rabies Post-exposure Prophylaxis in Ontario:

Epidemiology of Rabies Post-exposure Prophylaxis in Ontario: Epidemiology of Rabies Post-exposure Prophylaxis in Ontario: 2007-2011 The CIPHI 2013 Ontario Branch Conference September 16-18, 2013 Karen Johnson, Senior Epidemiologist Communicable Diseases Prevention

More information

Weekly May 29, 2009 / 58(20);

Weekly May 29, 2009 / 58(20); 1 of 5 8/23/2009 12:13 Weekly May 29, 2009 / 58(20);557-561 On September 29, 2008, the Ravalli County Public Health Department (RCPHD) notified the Montana Department of Public Health and Human Services

More information

Rabies. By Alexa Smith. Rabies Virus (Rabies); Etiological agent Family Rhabdoviridae. Genus- lyssavirus (1). Transmission:

Rabies. By Alexa Smith. Rabies Virus (Rabies); Etiological agent Family Rhabdoviridae. Genus- lyssavirus (1). Transmission: Rabies By Alexa Smith Rabies Virus (Rabies); Etiological agent Family Rhabdoviridae. Genus- lyssavirus (1). Transmission: The virus can enter a host via a parenteral route. The saliva of the infected host

More information

The Epidemiology of Human Rabies Postexposure Prophylaxis in Virginia, 2002 and 2003

The Epidemiology of Human Rabies Postexposure Prophylaxis in Virginia, 2002 and 2003 Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2011 The Epidemiology of Human Rabies Postexposure Prophylaxis in Virginia, 2002 and 2003 Marilyn Goss Haskell

More information

Page 1 of 11 Medical Summary RABIES GENERAL INFORMATION Introduction Rabies is an acute, progressive infection of the central nervous system caused by neurotropic viruses in the family Rhabdoviridae, genus

More information

Rabies. By Rosa Reynoso. Rabies; Etiological Agent: Rhabdoviridae family Lyssavirus genus type (4)

Rabies. By Rosa Reynoso. Rabies; Etiological Agent: Rhabdoviridae family Lyssavirus genus type (4) Rabies By Rosa Reynoso Rabies; Etiological Agent: Rhabdoviridae family Lyssavirus genus type (4) Transmision: It is a zoonotic disease transmitted from infected animals to humans (4). Infected animals

More information

IMOGAM RABIES PASTEURIZED - HUMAN RABIES IMMUNOGLOBULIN. Active ingredient: Human proteins mg

IMOGAM RABIES PASTEURIZED - HUMAN RABIES IMMUNOGLOBULIN. Active ingredient: Human proteins mg IMOGAM RABIES PASTEURIZED - HUMAN RABIES IMMUNOGLOBULIN COMPOSITION 1 ml of human rabies immunoglobulin contains: Active ingredient: Human proteins 100 180 mg containing (IgG class) human rabies immunoglobulins

More information

Updates in rabies vaccine protocols and diagnostic techniques used globally and nationally

Updates in rabies vaccine protocols and diagnostic techniques used globally and nationally Updates in rabies vaccine protocols and diagnostic techniques used globally and nationally Susan Moore, Rabies Laboratory/KSVDL/College of Veterinary Medicine/Kansas State University, Manhattan, KS 66502,

More information

GENUS LYSSAVIRUS IT IS ALMOST A 100% FATAL DISEASE OF HUMANS AND OTHER ANIMALS.

GENUS LYSSAVIRUS IT IS ALMOST A 100% FATAL DISEASE OF HUMANS AND OTHER ANIMALS. GENUS LYSSAVIRUS RABIES VIRUS IT IS ALMOST A 100% FATAL DISEASE OF HUMANS AND OTHER ANIMALS. IT HAS BEEN KNOWN SINCE THE 23 CENTURY B.C. RABIES IS PRESENT IS THE SALIVA OF RABID ANIMALS AND IS TRANSMITTED

More information

Animal Bites and Rabies. Patty W. Wright, M.D. 2018

Animal Bites and Rabies. Patty W. Wright, M.D. 2018 Animal Bites and Rabies Patty W. Wright, M.D. 2018 Objectives To inform participants about the treatment of common animal bites To discuss the indications for and administration of pre- and post-exposure

More information

Rabies in South Africa and the FIFA Soccer World Cup Travelers awareness for an endemic but neglected disease

Rabies in South Africa and the FIFA Soccer World Cup Travelers awareness for an endemic but neglected disease review Human Vaccines 6:5, 385-389; May 2010; 2010 Landes Bioscience REVIEW Rabies in South Africa and the FIFA Soccer World Cup Travelers awareness for an endemic but neglected disease Claudius Malerczyk,

More information

Management of Potential Rabies Exposures Guideline, 2018

Management of Potential Rabies Exposures Guideline, 2018 Ministry of Health and Long-Term Care Management of Potential Rabies Exposures Guideline, 2018 Population and Public Health Division, Ministry of Health and Long-Term Care Effective: January 1, 2018 or

More information

Republic of the Philippines. Department of Health OFFICE OF THE SECRETARY. June 8, 2009 ADMINISTRATIVE ORDER. No:

Republic of the Philippines. Department of Health OFFICE OF THE SECRETARY. June 8, 2009 ADMINISTRATIVE ORDER. No: Republic of the Philippines Department of Health OFFICE OF THE SECRETARY June 8, 2009 ADMINISTRATIVE ORDER No: 2009-0027 1 / 22 SUBJECT: Amendment to AO 2007-0029 regarding the Revised Guidelines on. I.

More information

LONG-TERM PROTECTIVE RABIES ANTIBODIES IN THAI CHILDREN AFTER PRE-EXPOSURE RABIES VACCINATION

LONG-TERM PROTECTIVE RABIES ANTIBODIES IN THAI CHILDREN AFTER PRE-EXPOSURE RABIES VACCINATION LONG-TERM PROTECTIVE RABIES ANTIBODIES IN THAI CHILDREN AFTER PRE-EXPOSURE RABIES VACCINATION Supawat Chatchen, Shakil Ibrahim, Pataporn Wisetsing and Kriengsak Limkittikul Department of Tropical Pediatrics,

More information

HEALTH ALERT August 26, 2008 RABIES VACCINE SUPPLY SHORTAGE

HEALTH ALERT August 26, 2008 RABIES VACCINE SUPPLY SHORTAGE ALAMEDA COUNTY HEALTH CARE SERVICES AGENCY David J. Kears, Director PUBLIC HEALTH DEPARTMENT Anthony Iton MD, JD, MPH, Director/Health Officer Division of Communicable Disease Control & Prevention Muntu

More information

THERAPEUTIC CLASSIFICATION

THERAPEUTIC CLASSIFICATION PRODUCT MONOGRAPH Rabies Immune Globulin [Human] HYPERRAB S/D Solvent / Detergent Treated 2 ml and 10 ml vials Injectable Solution Manufacturer s Standard THERAPEUTIC CLASSIFICATION Passive Immunizing

More information

Evidence to Recommendation Table 1

Evidence to Recommendation Table 1 Evidence to Recommendation Table 1 Questions: Can the duration of the entire course and/or the number of doses administered of current PEP regimens be reduced while maintaining immunogenicity and effectiveness?

More information

Rabies immunoprophylaxis strategy in travelers

Rabies immunoprophylaxis strategy in travelers Journal of Wilderness Medicine 2, 15-21 (1991) ORIGINAL ARTICLE Rabies immunoprophylaxis strategy in travelers D.R. SHLIM*, E. SCHWARTZ and R. HOUSTON CIWEC Clinic, POB 1340, Kathmandu, Nepal We present

More information

2018 Infection Prevention and Control Update. Lisa Caffery, MS,BSN,RN- BC,CIC, FAPIC

2018 Infection Prevention and Control Update. Lisa Caffery, MS,BSN,RN- BC,CIC, FAPIC 2018 Infection Prevention and Control Update Lisa Caffery, MS,BSN,RN- BC,CIC, FAPIC Influenza Influenza (1/19/18) Iowa activity IDPH has investigated 40 outbreaks in nursing homes 29 Deaths Activity will

More information

RABIES IN CHILDREN WHEN TO CONSIDER RABIES AND WHEN TO VACCINATE. Anja Poulsen MD PhD 2017

RABIES IN CHILDREN WHEN TO CONSIDER RABIES AND WHEN TO VACCINATE. Anja Poulsen MD PhD 2017 RABIES IN CHILDREN WHEN TO CONSIDER RABIES AND WHEN TO VACCINATE Anja Poulsen MD PhD 2017 WILL YOU VACCINATE AGAINST RABIES? Mum, dad, children: 9 years old and 12 years old. a. 3 weeks travel to Vietnam,

More information

Rabies. By: Christopher Solomon. Disease: Rabies etiologic agent: Lyssavirus (1)

Rabies. By: Christopher Solomon. Disease: Rabies etiologic agent: Lyssavirus (1) Rabies By: Christopher Solomon Disease: Rabies etiologic agent: Lyssavirus (1) Transmission: Transmission of this disease is most often transmitted by the bite of an infected or rabid animal (2). Reservoirs:

More information

New CDC LN34 Test for Rabies Has the Potential to Improve Disease Management

New CDC LN34 Test for Rabies Has the Potential to Improve Disease Management New CDC LN34 Test for Rabies Has the Potential to Improve Disease Management In May 2018, the United States (US) Centers for Disease Control and Prevention (CDC) announced that it had developed a new rabies

More information

DISEASE. Recommended Childhood Immunization Schedule, Minnesota, 1998

DISEASE. Recommended Childhood Immunization Schedule, Minnesota, 1998 MINNESOTA DEPAR ARTMENT OF HEALTH DISEASE CONTR ONTROL OL NEW EWSLETTER Volume 26, Number 4 (pages 29-36) May/June 1998 Recommended Childhood Immunization Schedule, Minnesota, 1998 The 1998 Recommended

More information

Produced by Agriculture and Extension Communications, Virginia Tech

Produced by Agriculture and Extension Communications, Virginia Tech revised 2005 publication 420-036 Rabies: Its Ecology, Control, and Treatment Kari Signor, former student, Department of Fisheries and Wildlife Sciences, Virginia Tech James Parkhurst, associate professor,

More information

Rabies Immune Globulin (Human)

Rabies Immune Globulin (Human) 14-7618-002 (Rev. April 1999) Rabies Immune Globulin (Human) BayRab Solvent/Detergent Treated DESCRIPTION Rabies Immune Globulin (Human) BayRab treated with solvent/detergent is a sterile solution of antirabies

More information

The Global Availability of Rabies Immune Globulin and Rabies Vaccine in Clinics Providing Direct Care to Travelers

The Global Availability of Rabies Immune Globulin and Rabies Vaccine in Clinics Providing Direct Care to Travelers 1 ORIGINAL ARTICLE The Global Availability of Rabies Immune Globulin and Rabies Vaccine in Clinics Providing Direct Care to Travelers Emily S. Jentes, PhD, Jesse D. Blanton, MPH, Katherine J. Johnson,

More information

For the use only of registered medical practitioners or a hospital or a laboratory

For the use only of registered medical practitioners or a hospital or a laboratory This package insert is continually updated: please read carefully before using a new pack! For the use only of registered medical practitioners or a hospital or a laboratory Package leaflet Rabipur PCEC

More information

Rabies. Issues for Travel. Kevin C. Kain MD Professor of Medicine, University of Toronto Director, Center for Travel and Tropical Medicine

Rabies. Issues for Travel. Kevin C. Kain MD Professor of Medicine, University of Toronto Director, Center for Travel and Tropical Medicine Rabies Issues for Travel Kevin C. Kain MD Professor of Medicine, University of Toronto Director, Center for Travel and Tropical Medicine Copyright 2017 by Sea Courses Inc. All rights reserved. No part

More information

Rabies Vaccine IMOVAX RABIES

Rabies Vaccine IMOVAX RABIES 046 90408-0 Rabies Vaccine IMOVAX RABIES WISTAR RABIES VIRUS STRAIN PM-1503-3M GROWN IN HUMAN DIPLOID CELL CULTURES Page 1 of 8 DESCRIPTION The Imovax Rabies Vaccine produced by Aventis Pasteur is a sterile,

More information

RABIES Pr P ese e n se t n er e : J. J. K a K m a bo b n o a n a (M.B. B Ch C. h B; B M.Med e ) d

RABIES Pr P ese e n se t n er e : J. J. K a K m a bo b n o a n a (M.B. B Ch C. h B; B M.Med e ) d RABIES Presenter: J.J. Kambona (M.B.Ch.B; M.Med) OBJECTIVES At the end of this session each student will be able to: 1. Define rabies. 2. Describe the epidemiology of rabies. 3. Describe the cause of rabies.

More information

Presented by. Professor Dr. Md. Zakir Hossain. Professor & Head Department of Medicine Rangpur Medical College & Hospital

Presented by. Professor Dr. Md. Zakir Hossain. Professor & Head Department of Medicine Rangpur Medical College & Hospital Rabies Presented by Professor Dr. Md. Zakir Hossain MBBS, FCPS, MD(Internal Medicine), FACP Professor & Head Department of Medicine Rangpur Medical College & Hospital Rangpur Medical College Rangpur Medical

More information

Rabies Immune Globulin (Human)

Rabies Immune Globulin (Human) 08940054 (Rev. November 2010) Rabies Immune Globulin (Human) HyperRAB S/D Solvent/Detergent Treated DESCRIPTION Rabies Immune Globulin (Human) HyperRAB S/D treated with solvent/detergent is a colorless

More information

FACTORS AFFECTING COMPLIANCE TO RABIES POST-EXPOSURE PROPHYLAXIS AMONG PEDIATRIC PATIENTS SEEN AT THE RESEARCH INSTITUTE FOR TROPICAL MEDICINE

FACTORS AFFECTING COMPLIANCE TO RABIES POST-EXPOSURE PROPHYLAXIS AMONG PEDIATRIC PATIENTS SEEN AT THE RESEARCH INSTITUTE FOR TROPICAL MEDICINE 56 ORIGINAL ARTICLE FACTORS AFFECTING COMPLIANCE TO RABIES POST-EXPOSURE PROPHYLAXIS AMONG PEDIATRIC PATIENTS SEEN AT THE RESEARCH INSTITUTE FOR TROPICAL MEDICINE AUTHORS: Ruth Faye Romero-Sengson *Philippine

More information

BATS AND RABIEÍS WHAT RABIES PROPHYLAXIS IS NEEDED AND WHEN?

BATS AND RABIEÍS WHAT RABIES PROPHYLAXIS IS NEEDED AND WHEN? BATS AND RABIEÍS WHAT RABIES PROPHYLAXIS IS NEEDED AND WHEN? ATHANASIOS MICHOS, MD, PHD, AND THEOKLIS ZAOUTIS, MD, MSCE There currently is no effective treatment for rabies, an almost always fatal disease.

More information

1.0 GOAL DEFINITIONS RISK ASSESSMENT...

1.0 GOAL DEFINITIONS RISK ASSESSMENT... Chapter I - Management of Specific Diseases Table of Contents 1.0 GOAL... 2 2.0 DEFINITIONS... 2 3.0 RISK ASSESSMENT... 3 3.1 EXPOSURE HISTORY... 4 3.1.1 Bats... 6 3.1.2 Terrestrial Mammals... 7 3.1.3

More information

ORV STRATEGY USING RABORAL V-RG FOR CONTROLLING RACOON RABIES

ORV STRATEGY USING RABORAL V-RG FOR CONTROLLING RACOON RABIES ORV STRATEGY USING RABORAL V-RG FOR CONTROLLING RACOON RABIES Emily W. Lankau DVM, PhD Scientific Consultant Merial, A Sanofi Company RABORAL V-RG : Product Description Produced by Merial Limited - Athens,

More information

Before It s Too Late... Post Exposure Prophylaxis. Objectives

Before It s Too Late... Post Exposure Prophylaxis. Objectives Before It s Too Late... Post Exposure Prophylaxis John Marshall, Pharm.D., BCPS Clinical Pharmacy Coordinator - Critical Care Beth Israel Deaconess Medical Center Boston, MA Objectives Differentiate events

More information

Rabies Postexposure Prophylaxis in a UK Travel Clinic: Ten Years Experience

Rabies Postexposure Prophylaxis in a UK Travel Clinic: Ten Years Experience Rabies Postexposure Prophylaxis in a UK Travel Clinic: Ten Years Experience 257 Limin Wijaya, MRCP (UK), Lisa Ford, MBBS, and David Lalloo, FRCP Department of Infectious Disease, Singapore General Hospital,

More information

Below you will find information about diseases, the risk of contagion, and preventive vaccinations.

Below you will find information about diseases, the risk of contagion, and preventive vaccinations. Vaccinations Below you will find information about diseases, the risk of contagion, and preventive vaccinations. DTP - Diphtheria Tetanus Polio Yellow fever Hepatitis A Typhoid fever Cerebrospinal meningitis

More information

Rabies. By Sarah C. Rivera

Rabies. By Sarah C. Rivera Rabies By Sarah C. Rivera Etiologic Agent: As a current veterinary technician, rabies is a word spoken all too often and without thinking twice. The clinic where I work is an approved rabies quarantine

More information

Rabies Response. Briefing for the Defense Health Board

Rabies Response. Briefing for the Defense Health Board Rabies Response Briefing for the Defense Health Board Steven B. Cersovsky, MD, MPH LTC(P), MC, USA Director, Epidemiology & Disease Surveillance 14 November 2011 UNCLASSIFIED Briefing Outline PURPOSE:

More information

Clinical Pharmacology

Clinical Pharmacology 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 RabAvert Rabies Vaccine Rabies Vaccine for Human Use Description RabAvert, Rabies Vaccine, produced by Novartis Vaccines and Diagnostics

More information

THE ASSIST ANT SECRETARY OF DEFENSE

THE ASSIST ANT SECRETARY OF DEFENSE THE ASSIST ANT SECRETARY OF DEFENSE 1200 DEFENSE PENTAGON WASHINGTON, DC 20301-1200 HEALTH AFFAIRS Nov 14, 2011 MEMORANDUM FOR ASSISTANT SECRETARY OF THE ARMY (MANPOWER AND RESERVE AFFAIRS) ASSISTANT SECRETARY

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the product: 1.1 Product name: EQUIRAB Rabies Antiserum - Equine 1.2 Strength: 1000 I.U. / 5 ml 1.3 Pharmaceutical Dosage form: Injection 2. Qualitative and

More information

Rabies Experts Highlight Barriers to Innovation in Rabies Education and Treatment. The Wistar Institute, Philadelphia, PA

Rabies Experts Highlight Barriers to Innovation in Rabies Education and Treatment. The Wistar Institute, Philadelphia, PA YOUR SOURCE FOR RABIES AWARENESS AND EDUCATION Rabies Experts Highlight Barriers to Innovation in Rabies Education and Treatment Broader awareness, increased vigilance, and innovative thinking are more

More information

Public Health Brief. A Newsletter on Current Public Health Topics

Public Health Brief. A Newsletter on Current Public Health Topics Public Health Brief A Newsletter on Current Public Health Topics Serving Adams, Arapahoe and Douglas Counties Phone 303/220-9200 Fax 303/741-4173 Follow us on Twitter @TCHDHealth and @TCHDEmergency Time

More information

Rabies Prevention Outreach Program Information for Providers

Rabies Prevention Outreach Program Information for Providers Rabies Prevention Outreach Program Information for Providers Contents Provider Message Evaluation & Treatment Algorithm Information on Rabies Animal Exposure Questionnaire/Interview Form Evaluating Rabies

More information

Infectious Disease Update

Infectious Disease Update Infectious Disease Update Karen Rose, RN BSN Communicable Disease Surveillance Nurse; Office of Epidemiology WeArePublicHealth.org twitter.com/maricopahealth facebook.com/mcdph Today s Updates: Influenza

More information

Pharmacology. Rabies Prophylaxis in the Emergency Department

Pharmacology. Rabies Prophylaxis in the Emergency Department Advanced Emergency Nursing Journal Vol. 35, No. 2, pp. 110 119 Copyright C 2013 Wolters Kluwer Health Lippincott Williams & Wilkins A P P L I E D Pharmacology Column Editor: Kyle A. Weant, PharmD, BCPS

More information

1.0 GOAL DEFINITIONS RISK ASSESSMENT...

1.0 GOAL DEFINITIONS RISK ASSESSMENT... Chapter I - Management of Specific Diseases Table of Contents 1.0 GOAL... 2 2.0 DEFINITIONS... 2 3.0 RISK ASSESSMENT... 3 3.1 EXPOSURE HISTORY... 4 3.1.1 Bats... 5 3.1.2 Terrestrial Mammals... 6 3.1.3

More information

One of your office personnel

One of your office personnel Doug Campos-Outcalt, MD, MPA Department of Family and Community Medicine, University of Arizona College of Medicine, Phoenix HIV postexposure prophylaxis: Who should get it? CORRESPONDENCE Doug Campos-Outcalt,

More information

One of the oldest recognized zoonotic diseases,

One of the oldest recognized zoonotic diseases, Epidemiology of Human Rabies in the United States, 1980 to 1996 Donald L. Noah, DVM, MPH; Cherie L. Drenzek, DVM, MS; Jean S. Smith, MS; John W. Krebs, MS; Lillian Orciari, MS; John Shaddock, BS; Dane

More information

RabAvert Rabies Vaccine

RabAvert Rabies Vaccine PRESCRIBING INFORMATION RabAvert Rabies Vaccine Rabies Vaccine for Human Use DESCRIPTION RabAvert Rabies Vaccine produced by GlaxoSmithKline GmbH is a sterile, freeze-dried vaccine obtained by growing

More information

Rabies Chitra S. Mani and Dennis L. Murray. DOI: /pir

Rabies Chitra S. Mani and Dennis L. Murray. DOI: /pir Rabies Chitra S. Mani and Dennis L. Murray Pediatrics in Review 2006;27;129 DOI: 10.1542/pir.27-4-129 The online version of this article, along with updated information and services, is located on the

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Challenges and Controversies in Vaccination TRAVEL VACCINES Resat Ozaras, MD, Professor, Istanbul University Cerrahpasa Medical School Infectious Dis. Dept. Risk of exposure The severity of the disease

More information

IMOGAM Rabies Pasteurized

IMOGAM Rabies Pasteurized PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION IMOGAM Rabies Pasteurized Rabies Immune Globulin, Pasteurized (Human) Solution for Injection (150 IU/mL) 2.0 ml vials and 10.0 ml vials Passive

More information

September 24, Dr. Amanda House: As far as I am aware, there are no definitive ante-mortem diagnostic tests for rabies in the horse.

September 24, Dr. Amanda House: As far as I am aware, there are no definitive ante-mortem diagnostic tests for rabies in the horse. September 24, 2009 Equine Rabies: What Every Horse Owner Should Know Guest: Hello, I recently purchased a TB Broodmare and would like to vaccinate her against Rabies. She is in foal on a April 06 2009

More information

ALTHOUGH HUMAN RABIES INfection

ALTHOUGH HUMAN RABIES INfection ORIGINAL CONTRIBUTION Appropriateness of Rabies Postexposure Prophylaxis ment for Animal Exposures Gregory J. Moran, MD David A. Talan, MD William Mower, MD, PhD Michael Newdow, MD, MPH Samuel Ong, MD

More information

RABIES PREVENTION IN TEXAS

RABIES PREVENTION IN TEXAS RABIES PREVENTION IN TEXAS Texas Department of State Health Services Zoonosis Control Stock No 6-108 Revised January 2016 1 CONTENTS INTRODUCTION 3 RABIES BIOLOGICALS 4 RATIONALE OF TREATMENT 5 MANAGEMENT

More information

CNS MODULE. Dr Hamed Al-Zoubi Ass. Prof. of Microbiology

CNS MODULE. Dr Hamed Al-Zoubi Ass. Prof. of Microbiology CNS MODULE Dr Hamed Al-Zoubi Ass. Prof. of Microbiology Enteroviruses Picornaviridae family 1. Enteroviruses a) Polioviruses types 1, 2 and 3 b) Coxsackieviruses A1-A24 (no A23), B1-B6 c) Echoviruses 1

More information

Herpes B Virus Exposure Protocol

Herpes B Virus Exposure Protocol Herpes B Virus Exposure Protocol ( This protocol has been revised based on new recommendations published in Clinical Infectious Diseases 2002; 35:1191-1203 which supercedes recommendations published in

More information

On track for 2020? Towards the WHO roadmap's targets for neglected tropical diseases

On track for 2020? Towards the WHO roadmap's targets for neglected tropical diseases MEEREB, 08 April 2015 Fondation Merieux, Lyon France On track for 2020? Towards the WHO roadmap's targets for neglected tropical diseases Dr Bernadette Abela-Ridder Department of Control of Neglected Tropical

More information

Philippe Lagacé Wiens M.D., DTM&H, FRCPC

Philippe Lagacé Wiens M.D., DTM&H, FRCPC Philippe Lagacé Wiens M.D., DTM&H, FRCPC ay yah FYAH lah yer kuhl 1. Describe the pathogenesis (steps in causing disease) of the rabies virus starting from the bite of an infected animal death of the

More information

Overview, Prevention, and Treatment of Rabies

Overview, Prevention, and Treatment of Rabies Overview, Prevention, and Treatment of Rabies Andrea Julia Nigg, Pharm.D., and Pamela L. Walker, Pharm.D. Each year, approximately 55,000 individuals worldwide die from an infection due to the rabies virus.

More information

General information. Costa Rica. Resources. Provided by NaTHNaC https://travelhealthpro.org.uk

General information. Costa Rica. Resources. Provided by NaTHNaC https://travelhealthpro.org.uk Costa Rica Capital City : "San José" Official Language: "Spanish" Monetary Unit: "Costa Rican colón ( )" General information The information on these pages should be used to research health risks and to

More information

Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children

Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children Vaccine 24 (2006) 1478 1482 Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children Pannipa Chulasugandha a,, Pakamatz Khawplod a, Piyalamporn Havanond b, Henry

More information

Recommendations on pre-exposure rabies vaccine schedules

Recommendations on pre-exposure rabies vaccine schedules Recommendations on pre-exposure rabies vaccine schedules 25 Jan 2018 PATRICK SOENTJENS Chief Medical Physician Travel Clinic ITM, Antwerp Med LtCol Leading Physician ID4C/Travel Clinic Mil Hospital, Brussels

More information

To provide the guidelines for the management of healthcare workers who have had an occupational exposure to blood and/or body fluids.

To provide the guidelines for the management of healthcare workers who have had an occupational exposure to blood and/or body fluids. TITLE/DESCRIPTION: MANAGEMENT OF OCCUPATIONAL EXPOSURE TO HBV, HCV, and HIV INDEX NUMBER: EFFECTIVE DATE: APPLIES TO: ISSUING AUTHORITY: 01/01/2009 01/01/2013 All GCC Countries GULF COOPERATION COUNCIL

More information

SCIENTIFIC STUDY GROUP ON TRAVEL MEDICINE NATIONAL CONSENSUS MEETING 2018

SCIENTIFIC STUDY GROUP ON TRAVEL MEDICINE NATIONAL CONSENSUS MEETING 2018 SCIENTIFIC STUDY GROUP ON TRAVEL MEDICINE WETENSCHAPPELIJKE STUDIEGROEP REISGENEESKUNDE/GROUPE D'ETUDE SCIENTIFIQUE DE LA MEDECINE DES VOYAGES NATIONAL CONSENSUS MEETING 2018 Neder-over-Heembeek, October

More information

Challenges and Preparedness for Emerging Zoonotic Diseases

Challenges and Preparedness for Emerging Zoonotic Diseases Challenges and Preparedness for Emerging Zoonotic Diseases SESSION VII - Emergency Management of Infectious Disease Outbreaks Disaster and Emergency Management in the Health Care Sector Dr Heidi Carroll,

More information

RABIES IMMUNOGLOBULIN. Kanishka Singh Choudhary* and Gunjan Jadon Shrinathji Institute of Pharmacy, Nathdwara. (Raj.)

RABIES IMMUNOGLOBULIN. Kanishka Singh Choudhary* and Gunjan Jadon Shrinathji Institute of Pharmacy, Nathdwara. (Raj.) Available online on www.ijarpb.com Review Article Received on 17/12/2013; Revised on 20/12/2014; Accepted 28/12/2013; Abstract RABIES IMMUNOGLOBULIN Kanishka Singh Choudhary* and Gunjan Jadon Shrinathji

More information

RABIPUR Product Information AUST R Page 1 of 14

RABIPUR Product Information AUST R Page 1 of 14 Page 1 of 14 DESCRIPTION RABIPUR Inactivated Rabies Virus Vaccine RABIPUR is an inactivated rabies virus vaccine, derived from the fixed-virus strain, Flury LEP. The virus is propagated in a Purified Chick

More information

Trends in national surveillance for rabies among bats in the United States ( ) 13 Transmission of rabies virus appears to be

Trends in national surveillance for rabies among bats in the United States ( ) 13 Transmission of rabies virus appears to be Trends in national surveillance for rabies among bats in the United States (1993 2000) Alison M. Mondul, MSPH; John W. Krebs, MS; James E. Childs, ScD Objective To describe surveillance trends and epidemiologic

More information

Continuing Dilemma in Endemic Infection: Rabies in Focus Nancy N. Bermal, MD Fellow: PPS, PIDSP

Continuing Dilemma in Endemic Infection: Rabies in Focus Nancy N. Bermal, MD Fellow: PPS, PIDSP Continuing Dilemma in Endemic Infection: Rabies in Focus Nancy N. Bermal, MD Fellow: PPS, PIDSP Conflict of Interest Disclosure Currently an employee of GSK Phils Objective To provide update to rabies

More information

by Jean Lang, a Emmanuel Feroldi, a and Nguyen Cong Vien b a Sanofi Pasteur, Marcy L etoile, France

by Jean Lang, a Emmanuel Feroldi, a and Nguyen Cong Vien b a Sanofi Pasteur, Marcy L etoile, France Pre-exposure Purified Vero Cell Rabies Vaccine and Concomitant Routine Childhood Vaccinations: 5-year Post-vaccination Follow-up Study of an Infant Cohort in Vietnam by Jean Lang, a Emmanuel Feroldi, a

More information

Platforms. Adolescent Immunization Update and the 16 Year Old Platform. Advisory Committee on Immunization Practices (ACIP)

Platforms. Adolescent Immunization Update and the 16 Year Old Platform. Advisory Committee on Immunization Practices (ACIP) Adolescent Immunization Update and the 16 Year Old Platform William Atkinson, MD, MPH Associate Director for Immunization Education Immunization Action Coalition Advisory Committee on Immunization Practices

More information

Knowledge, Attitudes, and Practices of French Travelers from Marseille Regarding Rabies Risk and Prevention

Knowledge, Attitudes, and Practices of French Travelers from Marseille Regarding Rabies Risk and Prevention 107 Knowledge, Attitudes, and Practices of French Travelers from Marseille Regarding Rabies Risk and Prevention Matthias Altmann, PharmD, MPH, Philippe Parola, MD, PhD, Jean Delmont, MD, Philippe Brouqui,

More information

ZIKA Virus and Mosquito Management. ACCG Rosmarie Kelly, PhD MPH 30 April 16

ZIKA Virus and Mosquito Management. ACCG Rosmarie Kelly, PhD MPH 30 April 16 ZIKA Virus and Mosquito Management ACCG Rosmarie Kelly, PhD MPH 30 April 16 What is Zika Virus? Zika virus (ZIKV) is a flavivirus related to yellow fever, dengue, West Nile, and Japanese encephalitis viruses.

More information

Guidelines for Vaccinating Pregnant Women

Guidelines for Vaccinating Pregnant Women Guidelines for Vaccinating Pregnant Women March 2012 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) MARCH 2012 Risk

More information

Dichotomous Key to Mammals of Southwest Ohio

Dichotomous Key to Mammals of Southwest Ohio Dichotomous Key to Mammals of Southwest Ohio 1a. Incisor teeth or holes from them are present in the upper jaw. Go to 2. 3a. (From 2a) Three incisors in each half of the upper jaw; length of skull is more

More information

POLIOVIRUS EXPOSURE/INJURY RESPONSE PROTOCOL

POLIOVIRUS EXPOSURE/INJURY RESPONSE PROTOCOL PLEASE POST THIS PAGE IN AREAS WHERE POLIOVIRUSES ARE USED UNIVERSITY OF CALIFORNIA, SAN FRANCISCO ENVIRONMENT, HEALTH AND SAFETY/BIOSAFETY POLIOVIRUS EXPOSURE/INJURY RESPONSE PROTOCOL Organism or Agent:

More information

September 25, Q: Can wild pigs carry rabies? A: I do not know why they could not carry this virus.

September 25, Q: Can wild pigs carry rabies? A: I do not know why they could not carry this virus. September 25, 2008 Understanding Equine Rabies Q: Can wild pigs carry rabies? A: I do not know why they could not carry this virus. Q: Are there disadvantages to administering the rabies vaccine? is there

More information

Epidemiology Update Hepatitis A

Epidemiology Update Hepatitis A December 2011 Epidemiology Update Hepatitis A Hepatitis A Key Points Between 2000 and 2010, 209 cases of hepatitis A were reported in Hennepin County residents. This represents 30% of the cases reported

More information

Questions and Answers on Ebola

Questions and Answers on Ebola Updated: August 26, 2014 The 2014 Ebola outbreak is the largest Ebola outbreak in history and the first in West Africa. The current outbreak is affecting four countries in West Africa: Guinea, Liberia,

More information